News & Events

November 2013

Share
masthead_enewsletter_CDINotebook

NOVEMBER 2013

Welcome to our monthly enewsletter, CDI Notebook, focused on keeping you abreast of the latest innovations using CDI’s iCell® and MyCell® products.

In this issue:
Webinars
Application Notes & Protocols
Conference News
Presentations/Posters

horizontal rule

Webinars

Modern Phenotypic Drug Discovery Is a Viable Pharma Strategy (Dec 5 | 11:30 am
EST | Free to SLAS members). Dr. Jonathan Lee, Eli Lilly and Company, describes a co-culture angiogenesis assay whose results indicate that modern phenotypic techniques can reliably provide information on compound structure-activity relationships during drug development.

Recording>>

Use of Human Induced Pluripotent Stem Cells for Predicting Diverse Cardiotoxicities
(Dec 11 | 11:00 am EST | Free). The Scientist brings together a panel of Pharma experts to discuss using human iPSC-derived cells in toxicological assays. Attendees are encouraged to share their experiences and ask questions during the live broadcast.

Recording>>

horizontal rule
AppNote

Application Notes & Protocols

Using iPSC-derived Hepatocytes as a Functional Model System for Human Hepatitis Research. This application note presents data suggesting the utility of iCell Hepatocytes for supporting host cell attachment and internalization of Hepatitis C virus, as well as serving as a suitable environment to study the viral replication life cycle.

Application Note>>

horizontal rule

Presentations/Posters

The following posters were presented at recent conferences and are accessible online:

NYSCF

New York Stem Cell Foundation 2013

ISSX 2013

horizontal rule
© 2014 Cellular Dynamics International, Inc.
525 Science Drive, Madison, WI 53711
+1 (608) 310-5100 or toll-free (877) 310-6688
www.cellulardynamics.com
Follow us: facebook16x16px_green linkedin16x16px_green twitter16x16px_green youtube16x16px_green